Related Experiment Video
Updated: Jul 25, 2025
12:35
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
Published on: March 17, 2012
28.2K
Palliative Care in Amyotrophic Lateral Sclerosis
Sebastiano Mercadante1, Lou'i Al-Husinat2
1Main Regional Center of Pain Relief and Supportive/Palliative Care (S.M.), La Maddalena Cancer Center, Palermo, Italy; Regional Home Care Program, SAMOT (S.M.), Palermo, Italy.
Journal of Pain and Symptom Management
|June 28, 2023
Summary
Palliative care is crucial for amyotrophic lateral sclerosis (ALS) patients, improving quality of life and symptoms. Early integration of palliative care and advance care planning ensures patient-centered support throughout the disease progression.
Area of Science:
- Neurology
- Palliative Medicine
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive, incurable neurodegenerative motor neuron disease.
- Palliative care principles are essential due to the disease's evolutive nature.
Purpose of the Study:
- To emphasize the importance of palliative care in managing ALS.
- To highlight the benefits of early and multidisciplinary intervention.
Main Methods:
- Review of palliative care principles in the context of ALS.
- Discussion of multidisciplinary team involvement.
- Exploration of advance care planning strategies.
Main Results:
- Palliative care involvement improves quality of life, symptom management, and prognosis in ALS patients.
- Early initiation of palliative care facilitates patient-centered care and effective communication.
- Advance care planning aligns medical treatment with patient values and goals.
Conclusions:
- Multidisciplinary palliative care is fundamental for comprehensive ALS management.
- Addressing key supportive care issues (cognitive, psychological, pain, nutrition, ventilation) is vital.
- Effective communication and consideration of palliative sedation are critical in end-of-life care for ALS.
Related Concept Videos
01:25Continuing Care
1.5K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
01:20Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
01:26Cross-bridge Cycle
117.7K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.7K
01:24Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
01:22Alzheimer's Disease: Treatment
222
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
222
01:15Parkinson's Disease: Overview
607
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
607